{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:42:09Z","timestamp":1769809329867,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Theranica"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Migraine and diabetes mellitus are highly prevalent chronic diseases, and their comorbidity presents management challenges, particularly when wearable medical technologies are used concurrently. Remote electrical neuromodulation (REN; Nerivio\u00ae) is an FDA-cleared non-pharmacological migraine therapy, and continuous glucose monitoring (CGM) systems are widely used in diabetes care. However, the safety and compatibility of simultaneous co-use have not yet been evaluated. This technical compatibility study aimed to assess whether REN operation affects CGM performance or interferes with glucose measurement integrity in diabetic adults. Methods: Twenty-one adults with diabetes using Dexcom G6\/G7 or FreeStyle Libre 2\/3 participated in a single-arm interventional study. During a 45 min session, participants operated the REN and CGM devices simultaneously on their smartphones, and the REN device was paused three times to compare CGM readings between REN ON and RED OFF conditions. The primary outcome was the mean absolute relative difference (MARDREN ON\/OFF), evaluated against a prespecified 5% threshold. Statistical analysis included the Wilcoxon test, with subgroup analysis by the CGM device family. Results: The median MARDREN ON\/OFF across all participants was 1.61% (IQR 0.84\u20132.44%), significantly below the 5% threshold (p &lt; 0.001). All participants achieved MARDREN ON\/OFF &lt; 5%. Subgroup analyses were consistent: the median MARDREN ON\/OFF was 1.70% (IQR 0.90\u20132.45%) for Dexcom and 1.05% (IQR 0.83\u20131.50%) for Abbott. No technical interference, Bluetooth disruptions, missed data transmission, or adverse events were observed. Conclusions: Simultaneous use of Nerivio\u00ae REN and CGM systems in adults with diabetes is compatible and safe, with no evidence of interference or significant deviations in glucose readings. These findings support the integrated and reliable use of REN and CGM wearables in adults with diabetes managing comorbid conditions.<\/jats:p>","DOI":"10.3390\/jcm15031097","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:09:22Z","timestamp":1769771362000},"page":"1097","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous Use of Continuous Glucose Monitoring (CGM) Systems and the Remote Electrical Neuromodulation (REN) Wearable for Patients with Comorbid Diabetes and Migraine: An Interventional Single-Arm Compatibility Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6025-8578","authenticated-orcid":false,"given":"Yara","family":"Asmar","sequence":"first","affiliation":[{"name":"Theranica, Netanya 4250438, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-6447","authenticated-orcid":false,"given":"Alit","family":"Stark-Inbar","sequence":"additional","affiliation":[{"name":"Theranica, Netanya 4250438, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7636-065X","authenticated-orcid":false,"given":"Maria Carmen","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ochsner Health, Covington, LA 70433, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1828-494X","authenticated-orcid":false,"given":"Katherine","family":"Podraza","sequence":"additional","affiliation":[{"name":"Ayer Neuroscience Institute Headache Center, Hartford HealthCare Medical Group, Mystic, CT 06355, USA"},{"name":"Department of Neurology, University of Connecticut School of Medicine, Farmington, CT 06030, USA"},{"name":"Ola Migraine Inc., Honolulu, HI 96814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Treppendahl","sequence":"additional","affiliation":[{"name":"Theranica, Bridgewater, NJ 08807, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Demirci","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetes, Connecticut Children\u2019s, Hartford, CT 06106, USA"},{"name":"Pediatric Endocrinology, Connecticut Children\u2019s Medical Center, University of Connecticut School of Medicine, Farmington, CT 06032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1035-0149","authenticated-orcid":false,"given":"Richelle","family":"deMayo","sequence":"additional","affiliation":[{"name":"Pediatric Headache Center, Connecticut Children\u2019s Specialty Care Center\u2014Westport, Westport, CT 06880, USA"},{"name":"Division of Pediatric Pain Medicine, University of Connecticut School of Medicine, Hartford, CT 06061, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liao, S., Qian, G., Huang, H., and Fu, H. (2025). Global trends and future projections of migraine burden in children aged 5 to 14 from 1990 to 2050. Front. Neurol., 16.","DOI":"10.3389\/fneur.2025.1641599"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10194-024-01868-2","article-title":"Epidemiological linkage between migraine and diabetes mellitus: A systematic review and meta-analysis","volume":"25","author":"Ha","year":"2024","journal-title":"J. Headache Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"gfaf177","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: Global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","article-title":"Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers","volume":"81","author":"Buse","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Islam, M.R., and Nyholt, D.R. (2022). Glucose-Related Traits and Risk of Migraine\u2014A Potential Mechanism and Treatment Consideration. Genes, 13.","DOI":"10.3390\/genes13050730"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rivera-Mancilla, E., Al-Hassany, L., Villal\u00f3n, C.M., and Maassen Van Den Brink, A. (2021). Metabolic Aspects of Migraine: Association with Obesity and Diabetes Mellitus. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.686398"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10194-024-01724-3","article-title":"Influence of metabolic state and body composition on the action of pharmacological treatment of migraine","volume":"25","author":"Bruijn","year":"2024","journal-title":"J. Headache Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2526353","DOI":"10.1001\/jamanetworkopen.2025.26353","article-title":"Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes","volume":"8","author":"Fang","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2022). Standards of Medical Care in Diabetes\u20142022 Abridged for Primary Care Providers. Clin. Diabetes, 40, 10\u201338.","DOI":"10.2337\/cd22-as01"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"0508","DOI":"10.34133\/research.0508","article-title":"A Wearable Integrated Microneedle Electrode Patch for Exercise Management in Diabetes","volume":"7","author":"Zhu","year":"2024","journal-title":"Research"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/head.13551","article-title":"Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","volume":"59","author":"Yarnitsky","year":"2019","journal-title":"Headache"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/head.14469","article-title":"Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial","volume":"63","author":"Tepper","year":"2023","journal-title":"Headache"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e55925","DOI":"10.2196\/55925","article-title":"Wearable Devices for Supporting Chronic Disease Self-Management: Scoping Review","volume":"13","author":"Gagnon","year":"2024","journal-title":"Interact. J. Med. Res."},{"key":"ref_15","first-page":"e68921","article-title":"The Role of Wearable Devices in Chronic Disease Monitoring and Patient Care: A Comprehensive Review","volume":"16","author":"Jafleh","year":"2024","journal-title":"Cureus"},{"key":"ref_16","unstructured":"U.S. Food and Drug Administration (2026, January 14). Applying Human Factors and Usability Engineering to Medical Devices: Guidance for Industry and Food and Drug Administration Staff, Available online: http:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM484097.pdf."},{"key":"ref_17","unstructured":"Feingold, K.R., Ahmed, S.F., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2025, October 12). Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control, Endotext, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279046\/."},{"key":"ref_18","first-page":"550","article-title":"Continuous Glucose Monitoring: A Review of Available Systems","volume":"44","author":"Funtanilla","year":"2019","journal-title":"Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1932296816662047","article-title":"Significance and Reliability of MARD for the Accuracy of CGM Systems","volume":"11","author":"Reiterer","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/dia.2023.0435","article-title":"The Myth of MARD (Mean Absolute Relative Difference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data","volume":"26","author":"Vigersky","year":"2024","journal-title":"Diabetes Technol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/19322968211001402","article-title":"Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197","volume":"16","author":"Freckmann","year":"2022","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/dom.12378","article-title":"Accuracy of two continuous glucose monitoring systems: A head-to-head comparison under clinical research centre and daily life conditions","volume":"17","author":"Kropff","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"ref_23","unstructured":"Food and Drug Administration, Department of Health and Human Services (2026, January 20). Available online: https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-H\/part-862\/subpart-B\/section-862.1355."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/dia.2021.0236","article-title":"Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations","volume":"23","author":"Bailey","year":"2021","journal-title":"Diabetes Technol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/dom.15504","article-title":"The role of real-time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management","volume":"26","author":"Reddy","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1874120701105010074","article-title":"Wireless Coexistence and EMC of Bluetooth and 802.11b Devices in Controlled Laboratory Settings","volume":"5","author":"Seidman","year":"2011","journal-title":"Open Biomed. Eng. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1109\/MEMC.2020.9328232","article-title":"A Case Study of Medical Device Wireless Coexistence Evaluation","volume":"9","author":"Guag","year":"2020","journal-title":"IEEE Electromagn. Compat. Mag."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1932296819855670","article-title":"Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space","volume":"14","author":"Heinemann","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1932296817697329","article-title":"Continuous Glucose Monitor Interference with Commonly Prescribed Medications: A Pilot Study","volume":"11","author":"Basu","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_30","unstructured":"U.S. Food and Drug Administration (2026, January 14). Digital Health Technologies for Remote Data Acquisition in Clinical Investigations, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/digital-health-technologies-remote-data-acquisition-clinical-investigations."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1097\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:32:29Z","timestamp":1769772749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031097"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031097","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}